Marjet D. Heitzer, Ph.D. - Publications
Affiliations: | 2005 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Solomon JD, Heitzer MD, Liu TT, Beumer JH, Parise RA, Normolle DP, Leach DA, Buchanan G, DeFranco DB. VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells. Molecular Cancer Research : McR. 12: 1166-80. PMID 24825850 DOI: 10.1158/1541-7786.Mcr-13-0395 | 0.57 | |||
2008 | Wolf IM, Heitzer MD, Grubisha M, DeFranco DB. Coactivators and nuclear receptor transactivation. Journal of Cellular Biochemistry. 104: 1580-6. PMID 18393355 DOI: 10.1002/Jcb.21755 | 0.554 | |||
2007 | Heitzer MD, Wolf IM, Sanchez ER, Witchel SF, DeFranco DB. Glucocorticoid receptor physiology. Reviews in Endocrine & Metabolic Disorders. 8: 321-30. PMID 18049904 DOI: 10.1007/S11154-007-9059-8 | 0.663 | |||
2007 | Heitzer MD, DeFranco DB. Hic-5/ARA55: a prostate stroma-specific AR coactivator. Steroids. 72: 218-20. PMID 17166536 DOI: 10.1016/J.Steroids.2006.11.010 | 0.59 | |||
2006 | Heitzer MD, DeFranco DB. Hic-5, an adaptor-like nuclear receptor coactivator. Nuclear Receptor Signaling. 4: e019. PMID 16862225 DOI: 10.1621/Nrs.04019 | 0.664 | |||
2006 | Heitzer MD, DeFranco DB. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells. Cancer Research. 66: 7326-33. PMID 16849583 DOI: 10.1158/0008-5472.Can-05-2379 | 0.623 | |||
2006 | Heitzer MD, DeFranco DB. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator. Molecular Endocrinology (Baltimore, Md.). 20: 56-64. PMID 16141357 DOI: 10.1210/Me.2005-0065 | 0.675 | |||
Show low-probability matches. |